West Nile Virus is making headlines this week, but it's not the only tropical disease found in the United States. Read Dr. Hotez's op ed for more.
Last Friday, Sabin president Dr. Peter Hotez was a featured guest on Soledad O’Brien’s CNN morning show “Starting Point.” On the show, Dr. Hotez discussed the burden of neglected tropical diseases (NTDs) globally and closer to home in the United States.
May 18, 2012 | Pacific Standard
Ahead of this weekend’s G8 Summit, Dr. Peter Hotez wrote an op-ed for Pacific Standard calling on G8 leaders to focus on NTD treatment and control as a cost-effective method to improve global health.
Reversing the World’s Neglect of Easily Cured Tropical Diseases
Dr. Peter Hotez
March 28, 2012
February 17, 2012
January 19, 2012 | The Atlantic
By Peter Hotez and James Kazura
Jan 19 2012, 8:06 AM ET
As long as we have a military presence in areas known for infectious diseases, we have to keep researchers working on improved treatments.
November 15, 2011 | Africa News Analysis (ANA)
By Musah Ibrahim Musah
“Addressing NTDs improves productivity and contribute to broader economic growth and prosperity of countries”
- says Dr Neeraj Mistry, Managing Director, Global Network for Neglected Tropical Diseases in an exclusive interview with ANA’s Musah Ibrahim Musah in Berlin, Germany.
November 8, 2011 | Voice of America
By Vidushi Sinha
A billion people around the world suffer from neglected tropical diseases, and the global health community is working to develop new drugs, vaccines and diagnostics. But experts note that success is uneven in part because of different rules and regulations in different countries for drug development and testing.
Dr. Peter Hotez, president of Sabin Vaccine Institute, says it is much easier to test new therapies in India than in other parts of the world.
November 3, 2011
Neglected Diseases Afflict S. Asia's Poor
By Vidushi Sinha
At a time when economists predict that South Asia's economy will grow, health experts point to hundreds of millions suffering from neglected infections, often as a result of poverty. In a series of new studies, researchers say many countries in South Asia bear a disproportionate burden of these diseases and have a need for new drugs and vaccines.